Physicians Pressured to Consider Race in Deciding Who to Treat
"Encouraged by the Biden administration, several states and municipalities are adopting policies that give preference to non-white patients in receiving potentially lifesaving treatments for COVID-19, including scarce monoclonal antibody infusions.
Health officials in Utah, New York City, and, initially, Minnesota developed race-based ranking systems after a key federal agency issued guidance documents citing race and ethnicity as factors in allocating therapies.
The U.S. Food and Drug Administration (FDA) “fact sheet” for emergency use authorization (EUA) of GlaxoSmithKline’s Sotrovimab, currently the only monoclonal antibody treatment effective against the Omicron variant, states “race or ethnicity” can “place individual patients at high risk for progression to severe COVID-19.”...Read all.
No comments:
Post a Comment